BIT
ZVRA icon

BlackRock Institutional Trust’s Zevra Therapeutics ZVRA Stock Holding History

BlackRock Institutional Trust’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$119K Hold
2,513
– – ﹤0.01% 3641
2016
Q3 		$181K Buy
2,513
+398
+19% +$28.3K ﹤0.01% 3623
2016
Q2 		$135K Sell
2,115
-103
-5% -$16.9K ﹤0.01% 3669
2016
Q1 		$515K Buy
2,218
+103
+5% +$24.9K ﹤0.01% 3455
2015
Q4 		$672K Hold
2,115
– – ﹤0.01% 3435
2015
Q3 		$656K Buy
2,115
+2,079
+5,775% +$637K ﹤0.01% 3441
2015
Q2 		$10K Buy
+36
New +$7.85K ﹤0.01% 3879

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.4B AUM 33.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Institutional Trust's ZVRA Position: Q4 2016 in Review

BlackRock Institutional Trust held its Zevra Therapeutics (ZVRA) position steady in Q4 2016 at 2,513 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3641.

BlackRock Institutional Trust first reported a position in ZVRA in Q2 2015 and has held it in 7 quarters since. The position peaked at $672K in Q4 2015. 36 funds tracked by Wall St. Rank hold ZVRA as of Q4 2016.

  • BlackRock Institutional Trust held 2,513 shares of Zevra Therapeutics worth $119K as of Q4 2016.
  • BlackRock Institutional Trust left its Zevra Therapeutics share count unchanged in Q4 2016.
  • Zevra Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3641 holding.
  • BlackRock Institutional Trust first reported a position in Zevra Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Institutional Trust's Zevra Therapeutics position peaked at $672K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.